Becton Dickinson's ROE % for the quarter that ended in Mar. 2026 was -5.04%. Becton Dickinson's PB Ratio for the quarter that ended in Mar. 2026 was 1.80.
Becton Dickinson's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -2.80%.
Becton Dickinson ROE % Adjusted to Book Value Related Terms
Becton Dickinson ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson ROE % Adjusted to Book Value Chart
BDX vs MDLN, RMD, WST: ROE % Adjusted to Book Value Comparison
For the Medical Instruments & Supplies subindustry, Becton Dickinson's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -2.80% mean?
Becton Dickinson (BDX) has a ROE % Adjusted to Book Value of -2.80% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's ROE % Adjusted to Book Value too high?
Becton Dickinson's current ROE % Adjusted to Book Value is -2.80%. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's ROE % Adjusted to Book Value compare to MDLN and RMD?
Becton Dickinson's ROE % Adjusted to Book Value of -2.80% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current ROE % Adjusted to Book Value is -2.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $190.96, compared to a current price of $151.38 — trading 20.7% below its estimated fair value. The current ROE % Adjusted to Book Value is -2.80%. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Becton Dickinson (BDX), the current ROE % Adjusted to Book Value is -2.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.7% below its estimated GF Value™ of $190.96.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
ROE % Adjusted to Book Value: -2.80%
GF Value™: $190.96 vs. price of $151.38 (20.7% below fair value)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
